✦ LIBER ✦

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study

✍ Scribed by Thatcher, N; Dazzi, H; Mellor, M; Ghosh, A; Carrington, B; Johnson, RJ; Loriaux, EM; Craig, RP

Book ID: 109836362
Publisher: Nature Publishing Group
Year: 1990
Tongue: English
Weight: 848 KB
Volume: 61
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1990.137

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interleukin-2 (rIL-2) with f

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies

✍ Ghosh, AK; Mellor, M; Prendiville, J; Thatcher, N 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 907 KB

Flavone acetic acid (FAA) with recombina

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. III: Cytokine studies

✍ Haworth, C; O'Reilly, SM; Chu, E; Rustin, GJS; Feldmann, M 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 857 KB

Flavone acetic acid (FAA) with recombina

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites

✍ Stratford, MR; Rustin, GJS; Dennis, MF; Watfa, RR; Howells, N; O'Reilly, SM 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 693 KB

Flavone acetic acid (FAA) with recombina

Flavone acetic acid (FAA) with recombinant interleukin-2 (TIL-2) in advanced malignant melanoma. II: Induction of nitric oxide production

✍ Thomsen, LL; Baguley, BC; Rustin, GJS; O'Reilly, SM 📂 Article 📅 1992 🏛 Nature Publishing Group 🌐 English ⚖ 768 KB

Recombinant interleukin-2 (rIL-2) given

Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study

✍ Thatcher, N; Dazzi, H; Johnson, RJ; Russell, S; Ghosh, AK; Moore, M; Chadwick, G 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 980 KB

Recombinant interferon alfa-2a in advanc

Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dtic

✍ G. R. C. McLeod; D. B. Thomson; P. Hersey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 384 KB

There is a rising incidence of malignant melanoma world-wide and, despite major improvements in i t s early diagnosis and treatment, the 10-year death rate remains at 20-25%. Evidence that the immune system has a role in the control of melanoma growth has encouraged immunological intervention. The r